146 related articles for article (PubMed ID: 30153293)
1. Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.
Li H; Hai Y; Lim SY; Toledo N; Crecente-Campo J; Schalk D; Li L; Omange RW; Dacoba TG; Liu LR; Kashem MA; Wan Y; Liang B; Li Q; Rakasz E; Schultz-Darken N; Alonso MJ; Plummer FA; Whitney JB; Luo M
PLoS One; 2018; 13(8):e0202997. PubMed ID: 30153293
[TBL] [Abstract][Full Text] [Related]
2. Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens.
Toledo NPL; Li H; Omange RW; Dacoba TG; Crecente-Campo J; Schalk D; Kashem MA; Rakasz E; Schultz-Darken N; Li Q; Whitney JB; Alonso MJ; Plummer FA; Luo M
Front Immunol; 2020; 11():1935. PubMed ID: 32983121
[TBL] [Abstract][Full Text] [Related]
3. Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.
Li H; Nykoluk M; Li L; Liu LR; Omange RW; Soule G; Schroeder LT; Toledo N; Kashem MA; Correia-Pinto JF; Liang B; Schultz-Darken N; Alonso MJ; Whitney JB; Plummer FA; Luo M
PLoS One; 2017; 12(10):e0186079. PubMed ID: 28982126
[TBL] [Abstract][Full Text] [Related]
4. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.
Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK
Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques.
Valentin A; Li J; Rosati M; Kulkarni V; Patel V; Jalah R; Alicea C; Reed S; Sardesai N; Berkower I; Pavlakis GN; Felber BK
Hum Vaccin Immunother; 2015; 11(8):2005-11. PubMed ID: 26125521
[TBL] [Abstract][Full Text] [Related]
6. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
[TBL] [Abstract][Full Text] [Related]
7. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557
[TBL] [Abstract][Full Text] [Related]
8. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
9. Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection.
Li H; Omange RW; Liang B; Toledo N; Hai Y; Liu LR; Schalk D; Crecente-Campo J; Dacoba TG; Lambe AB; Lim SY; Li L; Kashem MA; Wan Y; Correia-Pinto JF; Seaman MS; Liu XQ; Balshaw RF; Li Q; Schultz-Darken N; Alonso MJ; Plummer FA; Whitney JB; Luo M
J Clin Invest; 2020 Dec; 130(12):6429-6442. PubMed ID: 32853182
[TBL] [Abstract][Full Text] [Related]
10. Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.
Andersson AC; Holst PJ
J Transl Med; 2016 Dec; 14(1):343. PubMed ID: 27998269
[TBL] [Abstract][Full Text] [Related]
11. Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques.
Alter G; Yu WH; Chandrashekar A; Borducchi EN; Ghneim K; Sharma A; Nedellec R; McKenney KR; Linde C; Broge T; Suscovich TJ; Linnekin T; Abbink P; Mercado NB; Nkolola JP; McMahan K; Bondzie EA; Hamza V; Peter L; Kordana N; Mahrokhian S; Seaman MS; Li W; Lewis MG; Lauffenburger DA; Hangartner L; Sekaly RP; Barouch DH
Cell; 2020 Oct; 183(1):185-196.e14. PubMed ID: 33007262
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE
J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081
[TBL] [Abstract][Full Text] [Related]
13. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
[TBL] [Abstract][Full Text] [Related]
14. Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques.
Yan J; Hokey DA; Morrow MP; Corbitt N; Harris K; Harris D; Weiner DB
Vaccine; 2009 May; 27(25-26):3260-6. PubMed ID: 19200811
[TBL] [Abstract][Full Text] [Related]
15. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
16. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.
De Rose R; Batten CJ; Smith MZ; Fernandez CS; Peut V; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Jan; 81(1):292-300. PubMed ID: 17050602
[TBL] [Abstract][Full Text] [Related]
18. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes.
Egan MA; Chong SY; Rose NF; Megati S; Lopez KJ; Schadeck EB; Johnson JE; Masood A; Piacente P; Druilhet RE; Barras PW; Hasselschwert DL; Reilly P; Mishkin EM; Montefiori DC; Lewis MG; Clarke DK; Hendry RM; Marx PA; Eldridge JH; Udem SA; Israel ZR; Rose JK
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):989-1004. PubMed ID: 15585086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
